9 completed. 6 Phase 4, 2 Phase 2, 1 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Completed 6 |
| Phase 2 | 2 | Completed 2 |
| Not applicable | 1 | Completed 1 |
| Phase 3 | 1 | Completed 1 |
Follow Insulin, Long-Acting: new trials by email Literature Review of Insulin, Long-Acting trials Research Report on Insulin, Long-Acting
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Rapid-Acting Mealtime Insulin in Children and Adolescents With Newly Diagnosed Type 1 Diabetes Mellitus Rapid-Acting Insulin, Long acting insulin - Diabetes Mellitus, Type 1 Diabetes | Phase 4 | Completed | Emory University | 24 | 2019-11-27 | 2021-09-30 |
| Long Acting Insulin Versus Multiple Dose Regimen for Control of Gestational Diabetes Mellitus Long acting insulin, multiple dose regimen - Long Acting Insulin in Control of Gestational Diabetes Mellitus | Phase 2 / Phase 3 | Completed | Ain Shams University | 148 | 2019-09-01 | 2021-09-08 |
| New Onset Type 1 Diabetes: Role of Exenatide Exenatide, Rapid and long acting insulin, long acting insulin + rapid acting + 1.25 mcg Exenatide - Type 1 Diabetes | Phase 4 | Completed | Albert Einstein College of Medicine | 13 | 2010-12-01 | 2021-08-04 |
| Sitagliptin Versus Insulin Dose Increase in Type 2 Diabetes on Insulin Treatment sitagliptin, insulin dose increase - Diabetes | Phase 4 | Completed | Seoul National University Bundang Hospital | 140 | 2010-04-01 | 2013-10-25 |
| Sitagliptin (DPP-4 Inhibitor) and NPH Insulin in Patients With T2D sitagliptin, NPH insulin - Type 2 Diabetes Mellitus | Phase 4 | Completed | University of Sao Paulo General Hospital | 40 | 2010-01-01 | 2015-11-18 |
| Levemir-Body Composition and Energy Metabolism Detemir or Glargine - Type 2 Diabetes | Phase 4 | Completed | Institut de Recherches Cliniques de Montreal | 42 | 2009-03-01 | 2014-05-07 |
| Treat-to-target Trial of Basal Insulin in Post-transplant Hyperglycemia Insulatard (long-acting insulin), Conventional - Hyperglycemia | Phase 2 | Completed | Marcus Saemann | 50 | 2009-01-01 | 2012-09-03 |
| Humalog® Mix50/50(tm) as a Treatment for Gestational Diabetes Insulin LISPRO, Insulin, Long-Acting and Insulin - Gestational Diabetes Mellitus | Phase 4 | Completed | Sansum Diabetes Research Institute | 40 | 2008-10-01 | 2022-06-08 |
| Insulin Secretion in Diabetes Before and After Glycemic Control insulin glargine - Diabetes, Hyperglycemia | Not applicable | Completed | US Department of Veterans Affairs | 17 | 2008-04-01 | 2015-01-15 |
Diabetes Mellitus (4) · Insulin Resistance (3) · Diabetes Mellitus, Type 1 (2) · Diabetes Mellitus, Type 2 (2) · Hyperglycemia (2) · Diabetes, Gestational (1)
Ain Shams University (1) · Albert Einstein College of Medicine (1) · Emory University (1) · Institut de Recherches Cliniques de Montreal (1) · Marcus Saemann (1) · Sansum Diabetes Research Institute (1) · Seoul National University Bundang Hospital (1) · US Department of Veterans Affairs (1) · University of Sao Paulo General Hospital (1)
United States (3) · Austria (1) · Brazil (1) · Canada (1) · Egypt (1) · South Korea (1)
David D'Alessio, MD (1) · Eric I Felner, MD (1) · Kristin Castorino, DO (1) · Maria ER Siva, MD, PhD (1) · Ranjitha Katikaneni, MB; BS (1) · Remi Rabasa-Lhoret, MD, PhD (1) · Wilfred Druml, MD (1)
PMID 22443183, PMID 24092826, PMID 32803882, PMID 36617389
R01DK077166 (1)